C-type natriuretic peptide: An endogenous inhibitor of vascular angiotensin-converting enzyme activity

Circulation

Volumn 93, Issue 6, 1996, Pages 1155-1159

  Davidson, Neil C ^a   Barr, Craig S ^a   Struthers, Allan D ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

angiotensin; atrial natriuretic factor; natriuretic peptides; peptides; vasoconstriction

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN I; ATRIAL NATRIURETIC FACTOR ALPHA; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDRALAZINE; LISINOPRIL; NATRIURETIC PEPTIDE TYPE C; SYNTHETIC PEPTIDE;

ADULT; ARTICLE; BRACHIAL ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FOREARM BLOOD FLOW; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INTRAARTERIAL DRUG ADMINISTRATION; MALE; NATRIURESIS; NORMAL HUMAN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RESISTANCE BLOOD VESSEL; VASCULAR ENDOTHELIUM; VASOCONSTRICTION;

EID: 0029935496     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.6.1155     Document Type: Article

References (22)

1. Sudoh T, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun. 1990;168: 863-870.
2. Suga S, Nakao K, Itoh H, Komatsu Y, Ogawa Y, Hama N, Imura H. Endothelial production of C-type natriuretic peptide and its marked augmentation by transforming growth factor-β. J Clin Invest. 1992;90:1145-1149.
3. Wei CM, Aarhus LL, Miller VM, Burnett JC. The actions of natriuretic peptides on isolated human saphenous veins and internal mammary arteries. J Am Coll Cardiol. 1994;23:177A. Abstract.
4. Porter JG, Catalano R, McEnroe G, Lewicki JA, Frotter AA. C type natriuretic peptide inhibits growth factor-dependent DNA synthesis in smooth muscle cells. Am J Physiol. 1992;263: C1001-C1006.
5. Hunt PJ, Richards AM, Espiner EA, Nicholls MG, Yandle TG. Bioactivity and metabolism of C-type natriuretic peptide in normal man. J Clin Endocrinol Metab. 1994;78:1428-1435.
6. Kurtz A, Della Bruna R, Pfeilschifter J, Taugner R, Bauer C. Atrial natriuretic peptide inhibits renin release from juxtaglomerular cells by a cGMP mediated process. Proc Natl Acad Sci USA. 1986;83: 4769-4773.
7. Delkers W, Kleiner S, Bähr V. Effects of incremental infusions of atrial natriuretic factor on aldosterone, renin and blood pressure in humans. Hypertension. 1988;12:462-446.
8. Kawaguchi H, Sawa H, Yasuda H. Effect of atrial natriuretic factor on angiotensin converting enzyme. J Hypertens. 1990;8:749-753.
9. Nussberger J, Brunner DB, Waeber B, Brunner HR. True versus immunoreactive angiotensin II in human plasma. Hypertension. 1985;7(suppl I):I-1-I-7.
10. Lyall F, Morton JJ, Lever AF, Cragoe EJ. Angiotensin II activates Na-H exchange and stimulates growth in cultured vascular smooth muscle cells. J Hypertens. 1988;6(suppl 4):S438-S441.
11. Holmquist B, Bünning P, Riordan JF. A continuous spectrophotometric assay for angiotensin converting enzyme. Anal Biochem. 1979;5:540-548.
12. Senn SJ. The use of baselines in clinical trials of bronchodilators. Stat Med. 1989;8:1339-1350.
13. Doorenbos CJ, Blauw GJ, van Brummelen P. Arterial and venous effects of atrial natriuretic peptide in the human forearm. Am J Hypertens. 1991;4:333-340.
14. Stingo AJ, Clavell AL, Heublein DM, Wei CM, Pittelkow MR, Burnett JC Jr. Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol. 1992;263: H1318-H1321.
15. Ames RP, Borkowski AJ, Sicinski AM, Laragh JH. Prolonged infusions of angiotensin II and norepinephrine and blood pressure, electrolyte balance, and aldosterone and cortisol secretion in normal man and in cirrhosis with ascites. J Clin Invest. 1965;44: 1171-1178.
16. Benjamin N, Cockcroft JR, Collier JG, Dollery CT, Ritter JM, Webb DJ. Local inhibition of converting enzyme and vascular responses to angiotensin and bradykinin in the human forearm. J Physiol. 1989;12:543-555.
17. Nakao K, Ogawa Y, Suga S, Imura H. Molecular biology and biochemistry of the natriuretic peptide system, II: natriuretic peptide receptors. J Hypertens. 1992;10:1111-1114.
18. Levin ER. Natriuretic peptide C-receptor: more than a clearance receptor. Am J Physiol. 1993;264:E483-E489.
19. Suga S, Nakao K, Mukoyama M, Arai H, Hosoda K, Ogawa Y, Imura H. Characterization of natriuretic peptide receptors in cultured cells. Hypertension. 1992;19:762-765.
20. Krulewitz AH, Fanburg BL. Stimulation of bovine endothelial cell angiotensin-1-converting enzyme activity by cyclic AMP-related agents. J Cell Physiol. 1986;129:147-150.
21. Wei CM, Hu S, Kim CH, Miller V, Burnett JC Jr. The in vitro actions of C-type natriuretic peptide in coronary arteries. Circulation. 1993;88(suppl 1):I-181. Abstract.
22. Bünning P, Riordan JF. Activation of angiotensin converting enzyme by monovalent anions. Biochemistry. 1983;22:110-116.